Cargando…
Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
Urothelial carcinoma is the sixth most common malignancy in the US. While most patients present with non-muscle-invasive disease, many will develop recurrent disease including some progressing to muscle invasive metastatic cancer. Treatment outcomes have remained poor and stagnant for those with mor...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790095/ https://www.ncbi.nlm.nih.gov/pubmed/29417045 http://dx.doi.org/10.2147/RRU.S125635 |